Concepedia

Lan Yao

LY

Statistics

Publications

4

Citations

165

H-Index

4

Active since

2018

Affiliations

Hebei Medical University(Current)

Fourth Hospital of Hebei Medical University

Lan Yao is an author at Hebei Medical University specializing in tumor biology, medicine, and cell biology.

ORCID

Top concepts

Publications per year

2018–2023

4

Publications

4

Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K/Akt/eNOS signaling pathway in diabetic tubulopathy

Lan Yao, Xianhui Liang, Yamin Liu et al. · Redox Biology · 2023 · 82 citations · Full text

Apatinib, a selective VEGFR2 inhibitor, improves the delivery of chemotherapeutic agents to tumors by normalizing tumor vessels in LoVo colon cancer xenograft mice

Kai Zhou, Jingwei Zhang, Qizhi Wang et al. · Acta Pharmacologica Sinica · 2018 · 37 citations · Full text

, , +10

Fatostatin inhibits the development of endometrial carcinoma in endometrial carcinoma cells and a xenograft model by targeting lipid metabolism

Lan Yao, Shu‐Cheng Chen, Wansheng Li · Archives of Biochemistry and Biophysics · 2020 · 31 citations

, , +8

Autophagy inhibitor potentiates the antitumor efficacy of apatinib in uterine sarcoma by stimulating PI3K/Akt/mTOR pathway

Shu‐Cheng Chen, Lan Yao · Cancer Chemotherapy and Pharmacology · 2021 · 15 citations

, , +10

1–4 of 4